GlaxoSmithKline Pakistan Limited (GLAXO)

PHARMACEUTICALSACIALLSHRKMIALLSHRKSE100KSE100PRMII30

342.84

+0.54%

As of 25-Aug-2026

52 Week RangeCurrent: 342.84

293.09459.94

Updated: 25-Aug-2026

1M+0.1%

3M-0.4%

1Y-8.6%

3Y+443.2%

5Y+295.3%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 21-Aug-2026

P/E

10.48x

P/B

3.04x

P/S

1.64x

EV/Sales

5.91x

EV/EBITDA

20.51x

Showing 37 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	16.81	7.73	1.68	20.52	31.48
DPS	7.00	0.00	0.00	10.00	17.00
BVPS	65.90	66.11	68.06	88.79	105.74
PER	20.58x	44.76x	205.93x	16.86x	10.99x
Div Yield	2.02%	0.00%	0.00%	2.89%	4.91%
PBV	5.25	5.23	5.08	3.90	3.27
EV/Sales	2.77x	2.52x	2.15x	1.70x	1.55x
Price/Sales	3.01x	2.63x	2.22x	1.80x	1.67x
EV/EBITDA	15.69x	36.70x	-44.56x	10.35x	5.57x
EV/Gross Profit	10.43x	14.49x	30.46x	6.75x	4.18x

Metric	2021	2022	2023	2024	2025
Gross Margin	26.56%	17.40%	7.05%	25.15%	37.00%
EBITDA Margin	17.65%	6.87%	-4.82%	16.39%	27.79%
Operating Margin	15.49%	4.77%	-6.71%	14.50%	25.64%
Pretax Margin	20.25%	12.20%	4.38%	17.12%	25.32%
Net Margin	14.60%	5.89%	1.08%	10.68%	15.21%

Metric	2021	2022	2023	2024	2025
ROE	27.84%	11.72%	2.50%	26.17%	32.36%
ROA	18.94%	7.46%	1.45%	15.71%	20.94%
ROTA	20.10%	6.05%	-9.05%	21.33%	35.30%
ROCE	25.67%	8.82%	-14.14%	29.46%	47.54%